ECOG PCO-RL; E2408 (Millennium) A 3-Arm Randomized Phase II Trial of Bendamustin Rituximab (BR) Followed by Rituximab vs Bortezomib-BR (BVR) Followed by

Project: Research project

Project Details

StatusFinished
Effective start/end date12/13/10 → 12/12/14

Funding

  • Frontier Science and Technology Research Foundation (PCO2408M-00)
  • Millennium Pharmaceuticals, Inc (PCO2408M-00)